Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Juli 2017 08:30 ET | Quelle: Marina Biotech, Inc.

Marina Biotech Announces the Appointment of Dr. Vuong Trieu as Executive Chairman

CITY OF INDUSTRY, CA--(Marketwired - Jul 5, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
26. Juni 2017 08:30 ET | Quelle: Marina Biotech, Inc.

Marina Biotech Appoints Chief Commercial Officer to Lead Sales and Marketing of Prestalia(R)

CITY OF INDUSTRY, CA--(Marketwired - Jun 26, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
06. Juni 2017 08:30 ET | Quelle: Marina Biotech, Inc.

Marina Biotech Acquires Prestalia(R), a U.S. FDA Approved Drug for Patients Whose Blood Pressure Is Not Adequately Controlled by Monotherapy

CITY OF INDUSTRY, CA--(Marketwired - Jun 6, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
30. Mai 2017 08:45 ET | Quelle: Marina Biotech, Inc.

Marina Biotech to Introduce Its Therapeutic Microbiome Programs Against Gastrointestinal Diseases

CITY OF INDUSTRY, CA--(Marketwired - May 30, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
27. April 2017 14:00 ET | Quelle: Marina Biotech, Inc.

Marina Biotech to Participate in Joseph Gunnar's Pioneers 2017 Conference on May 2

CITY OF INDUSTRY, CA--(Marketwired - Apr 27, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
05. April 2017 08:45 ET | Quelle: Marina Biotech, Inc.

Marina Biotech Provides Business Update

CITY OF INDUSTRY, CA--(Marketwired - Apr 5, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative...
03. April 2017 09:00 ET | Quelle: Marina Biotech, Inc.

Marina Biotech Signs Definitive Agreement with Windlas Healthcare to Manufacture IT-102 FDC Bi-Layer Tablet

CITY OF INDUSTRY, CA--(Marketwired - Apr 3, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
29. März 2017 09:05 ET | Quelle: Marina Biotech, Inc.

Marina Biotech to Present Data on IT-102 and IT-103 at 2017 American Association for Cancer Research Annual Meeting

CITY OF INDUSTRY, CA--(Marketwired - Mar 29, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
24. März 2017 09:10 ET | Quelle: Marina Biotech, Inc.

Marina Biotech to Present Data on Vascular Resistance and Cancer at the Endocrine Society Annual Meeting on April 1

CITY OF INDUSTRY, CA--(Marketwired - Mar 24, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
13. März 2017 09:05 ET | Quelle: Marina Biotech, Inc.

Marina Biotech to Present A Late Breaking Poster on the Safety and Tolerability of CEQ508 for FAP at the Society of Toxicology 56th Annual Meeting on March 16

CITY OF INDUSTRY, CA--(Marketwired - Mar 13, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...

Nächste Seite